Armistice Capital Adds Diagnostics and Device Stocks to a Portfolio Still Anchored in Index OptionsSeptember 23, 2026
Armistice Capital Adds Diagnostics and Device Stocks to a Portfolio Still Anchored in Index OptionsBy Josie SimonSeptember 23, 2026 Armistice Capital put $75 million into four new stocks during the second quarter: a genomics…
